The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis

scientific article published on 25 November 2014

The Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12013-014-0413-7
P932PMC publication ID4457911
P698PubMed publication ID25420534
P5875ResearchGate publication ID268873675

P2093author name stringPing Wu
Xiuli Wang
Fangyuan Jia
Yonggao Guo
P2860cites workInterleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitisQ44942842
IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.Q54648083
P433issue1
P304page(s)103-106
P577publication date2014-11-25
P1433published inCell Biochemistry and BiophysicsQ15755135
P1476titleThe Effects of Armillarisin A on Serum IL-1β and IL-4 and in Treating Ulcerative Colitis
P478volume72

Reverse relations

cites work (P2860)
Q37720993Anti-Inflammatory Effect of Dialyzable Leukocyte Extract in Autoimmune Prostatitis: Evaluation in Animal Model.
Q92277701Barbaloin Attenuates Mucosal Damage in Experimental Models of Rat Colitis by Regulating Inflammation and the AMPK Signaling Pathway
Q49339629Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation
Q88165803Norisoboldine, a natural aryl hydrocarbon receptor agonist, alleviates TNBS-induced colitis in mice, by inhibiting the activation of NLRP3 inflammasome

Search more.